United States Pharmaceuticals

Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals experienced one notable insider trading transaction over the past ninety days, involving a proposed sale by a former officer. This activity follows a period of broader divestment by company leadership. The stock has demonstrated an 8.4% price increase recently, supported by a 20% earnings report beat last November.
Ticker: IRWD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ironwood Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
Shetzline Michael Former Officer Officer
Transaction date
Proposed sale
Price
174.80
Quantity 12,054
Value US$1,573,662
4.0
Silver Ronald PFO & PAO Officer
Transaction date
Planned sale
Price
197.41
Quantity 40,241 +8.0%
Value US$4,618,688
4.0
RONALD SILVER Officer Officer
Transaction date
Proposed sale
Price
353.33
Quantity 37,954
Value US$4,007,157
0.9
McHugh Julie Non-Executive Director
Transaction date
Planned sale
Price
3.73
Quantity 21,571 -7.9%
Value US$80,460
0.9
JULIE MCHUGH Director Non-Executive Director
Transaction date
Proposed sale
Price
3.69
Quantity 21,571
Value US$79,597
2.7
DENNER ALEXANDER J Non-Executive Director
Transaction date
Sale
Price
3.31
Quantity 5,800 -0.1%
Value US$19,198
2.7
DENNER ALEXANDER J Non-Executive Director
Transaction date
Sale
Price
3.05
Quantity 6,725,000 -42.2%
Value US$20,511,250
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Sale
Price
3.66
Quantity 12,621 -4.8%
Value US$46,193
3.1
Martini Gregory S. Chief Financial Officer Officer
Transaction date
Sale
Price
3.66
Quantity 11,457 -6.7%
Value US$41,933
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
3.66
Quantity 19,053 -5.0%
Value US$69,734
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
3.66
Quantity 103,526 -6.5%
Value US$378,905
2.5
Gaskins Tammi L Chief Commercial Officer Officer
Transaction date
Sale
Price
3.66
Quantity 11,239 -5.0%
Value US$41,135
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Sale
Price
3.81
Quantity 11,552 -4.2%
Value US$44,013
4.1
Shetzline Michael SVP, CMO, Head-Res&Drug Officer
Transaction date
Sale
Price
3.81
Quantity 15,570 -2.8%
Value US$59,322
3.1
Martini Gregory S. Chief Financial Officer Officer
Transaction date
Sale
Price
3.81
Quantity 10,487 -5.7%
Value US$39,955
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
3.81
Quantity 17,439 -4.4%
Value US$66,443
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
3.81
Quantity 94,757 -5.6%
Value US$361,024
2.5
Gaskins Tammi L Chief Commercial Officer Officer
Transaction date
Sale
Price
3.81
Quantity 10,287 -4.4%
Value US$39,193
2.5
Gaskins Tammi L Officer Officer
Transaction date
Proposed sale
Price
4.61
Quantity 19,775
Value US$91,163
3.1
Martini Gregory S. Officer Officer
Transaction date
Proposed sale
Price
4.61
Quantity 20,163
Value US$92,951
4.1
Shetzline Michael Officer Officer
Transaction date
Proposed sale
Price
4.61
Quantity 29,937
Value US$138,010
4.2
John Minardo Officer Officer
Transaction date
Proposed sale
Price
4.61
Quantity 33,528
Value US$154,564
4.2
MCCOURT Thomas A Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.61
Quantity 182,185
Value US$839,873
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Planned sale
Price
4.60
Quantity 35,416 -11.3%
Value US$162,914
4.0
RONALD SILVER Officer Officer
Transaction date
Proposed sale
Price
4.27
Quantity 35,416
Value US$151,226
2.5
Gaskins Tammi L Chief Commercial Officer Officer
Transaction date
Sale
Price
3.32
Quantity 6,016 -2.5%
Value US$19,973
2.5
Gaskins Tammi L Officer Officer
Transaction date
Proposed sale
Price
3.37
Quantity 6,324
Value US$21,312
2.5
Gaskins Tammi L Chief Commercial Officer Officer
Transaction date
Sale
Price
0.84
Quantity 1,316 -0.5%
Value US$1,105
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Sale
Price
0.84
Quantity 2,846 -1.0%
Value US$2,391
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
0.84
Quantity 7,754 -1.9%
Value US$6,513
3.1
Martini Gregory S. Chief Financial Officer Officer
Transaction date
Sale
Price
0.84
Quantity 1,265 -0.7%
Value US$1,063
2.5
Gaskins Tammi L Officer Officer
Transaction date
Proposed sale
Price
0.88
Quantity 1,406
Value US$1,237
3.1
Martini Gregory S. Officer Officer
Transaction date
Proposed sale
Price
0.88
Quantity 1,351
Value US$1,189
4.2
John Minardo Officer Officer
Transaction date
Proposed sale
Price
0.88
Quantity 8,281
Value US$7,287
2.5
Gaskins Tammi L Officer Officer
Transaction date
Proposed sale
Price
0.59
Quantity 2,814
Value US$1,660
4.2
MCCOURT Thomas A Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.59
Quantity 14,661
Value US$8,650
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.58
Quantity 13,353 -1.2%
Value US$7,745
2.5
Gaskins Tammi L Chief Commercial Officer Officer
Transaction date
Sale
Price
0.58
Quantity 2,563 -1.0%
Value US$1,487
4.1
Shetzline Michael SVP, CMO, Head-Res&Drug Officer
Transaction date
Sale
Price
1.76
Quantity 41,269 -6.9%
Value US$72,633
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.76
Quantity 139,064 -10.7%
Value US$244,753
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
1.76
Quantity 38,938 -8.7%
Value US$68,531
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Sale
Price
1.76
Quantity 12,048 -4.1%
Value US$21,204
3.1
Martini Gregory S. Chief Financial Officer Officer
Transaction date
Sale
Price
1.76
Quantity 12,052 -6.2%
Value US$21,212
3.1
Martini Gregory S. Officer Officer
Transaction date
Proposed sale
Price
1.94
Quantity 12,347
Value US$23,953
4.2
John Minardo Officer Officer
Transaction date
Proposed sale
Price
1.94
Quantity 39,889
Value US$77,385
4.1
Shetzline Michael Officer Officer
Transaction date
Proposed sale
Price
1.94
Quantity 42,274
Value US$82,012
4.2
MCCOURT Thomas A Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.94
Quantity 142,454
Value US$276,361
3.7
Davis Andrew Officer Officer
Transaction date
Proposed sale
Price
4.00
Quantity 60,434
Value US$241,736
2.2
Emany Sravan Kumar SVP, COO and CFO Officer
Transaction date
Sale
Price
4.08
Quantity 11,001 -3.4%
Value US$44,884
3.7
Davis Andrew SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
4.08
Quantity 5,360 -1.8%
Value US$21,869
3.7
Davis Andrew Officer Officer
Transaction date
Proposed sale
Price
4.11
Quantity 6,090
Value US$25,030
2.2
Emany Sravan Kumar Officer Officer
Transaction date
Proposed sale
Price
4.11
Quantity 12,500
Value US$51,375
4.0
Silver Ronald Principal Accounting Officer Officer
Transaction date
Sale
Price
4.27
Quantity 3,107 -1.9%
Value US$13,267
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
4.27
Quantity 9,910 -3.4%
Value US$42,316
4.2
John Minardo Officer Officer
Transaction date
Proposed sale
Price
4.05
Quantity 11,726
Value US$47,490
0.9
McHugh Julie Non-Executive Director
Transaction date
Planned sale
Price
6.29
Quantity 22,766 -14.0%
Value US$143,198
0.9
JULIE MCHUGH Director Non-Executive Director
Transaction date
Proposed sale
Price
6.35
Quantity 22,766
Value US$144,564
3.6
Moukheibir Catherine Non-Executive Director
Transaction date
Sale
Price
6.61
Quantity 35,574 -42.2%
Value US$235,144
3.6
Moukheibir Catherine Director Non-Executive Director
Transaction date
Proposed sale
Price
6.60
Quantity 35,574
Value US$234,767
3.6
Moukheibir Catherine Non-Executive Director
Transaction date
Sale
Price
6.36
Quantity 44,426 -34.5%
Value US$282,549
3.6
Moukheibir Catherine Director Non-Executive Director
Transaction date
Proposed sale
Price
6.36
Quantity 44,426
Value US$282,490
4.2
John Minardo Chief Legal Officer Officer
Transaction date
Sale
Price
6.45
Quantity 17,404 -5.6%
Value US$112,256
3.7
Davis Andrew SVP, Chief Business Officer Officer
Transaction date
Sale
Price
6.45
Quantity 22,725 -7.3%
Value US$146,576
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.45
Quantity 67,618 -5.6%
Value US$436,136
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.45
Quantity 67,618 -5.6%
Value US$436,136
4.1
Shetzline Michael CMO,SVP,Head-Res&Drug Officer
Transaction date
Sale
Price
6.45
Quantity 16,128 -3.8%
Value US$104,026
4.1
Shetzline Michael CMO,SVP,Head-Res&Drug Officer
Transaction date
Sale
Price
6.45
Quantity 16,128 -3.8%
Value US$104,026
3.7
Davis Andrew Officer Officer
Transaction date
Proposed sale
Price
6.64
Quantity 25,105
Value US$166,697
4.2
John Minardo Officer Officer
Transaction date
Proposed sale
Price
6.64
Quantity 19,228
Value US$127,674
4.1
Shetzline Michael Officer Officer
Transaction date
Proposed sale
Price
6.64
Quantity 17,820
Value US$118,325
4.2
MCCOURT Thomas A Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.64
Quantity 74,705
Value US$496,041
1.2
Duane Jon R Non-Executive Director
Transaction date
Purchase
Price
8.70
Quantity 6,920 +6.1%
Value US$60,204
2.2
Emany Sravan Kumar SVP, Chief Financial Officer Officer
Transaction date
Purchase
Price
9.38
Quantity 10,684 +3.7%
Value US$100,216
4.1
Shetzline Michael CMO,SVP,Head-Res&Drug Officer
Transaction date
Sale
Price
15.24
Quantity 38,618 -10.2%
Value US$588,538
4.2
MCCOURT Thomas A Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.24
Quantity 177,164 -17.5%
Value US$2,699,979
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-23 2026-09-24 PrS Proposed sale
4.1
Shetzline Michael

Former Officer

Officer
12,054
174.80
US$1,573,662 		12,054 174.80 US$1,573,662
2026-07-09 2026-07-07 PlS Planned sale
4.0
Silver Ronald

PFO & PAO

Officer
40,241 +8.0%
197.41
US$4,618,688 		40,241 +8.0% 197.41 US$4,618,688
2026-07-07 2026-07-07 PrS Proposed sale
4.0
RONALD SILVER

Officer

Officer
37,954
353.33
US$4,007,157 		37,954 353.33 US$4,007,157
2026-06-17 2026-06-16 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
21,571 -7.9%
3.73
US$80,460 		21,571 -7.9% 3.73 US$80,460
2026-06-16 2026-06-16 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
21,571
3.69
US$79,597 		21,571 3.69 US$79,597
2026-03-17 2026-03-17 S Sale
2.7
DENNER ALEXANDER J
Non-Executive Director
5,800 -0.1%
3.31
US$19,198 		5,800 -0.1% 3.31 US$19,198
2026-03-17 2026-03-17 S Sale
2.7
DENNER ALEXANDER J
Non-Executive Director
6,725,000 -42.2%
3.05
US$20,511,250 		6,725,000 -42.2% 3.05 US$20,511,250
2026-02-25 2026-02-24 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
12,621 -4.8%
3.66
US$46,193 		12,621 -4.8% 3.66 US$46,193
2026-02-25 2026-02-24 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
11,457 -6.7%
3.66
US$41,933 		11,457 -6.7% 3.66 US$41,933
2026-02-25 2026-02-24 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
19,053 -5.0%
3.66
US$69,734 		19,053 -5.0% 3.66 US$69,734
2026-02-25 2026-02-24 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
103,526 -6.5%
3.66
US$378,905 		103,526 -6.5% 3.66 US$378,905
2026-02-25 2026-02-24 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
11,239 -5.0%
3.66
US$41,135 		11,239 -5.0% 3.66 US$41,135
2026-02-25 2026-02-23 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
11,552 -4.2%
3.81
US$44,013 		11,552 -4.2% 3.81 US$44,013
2026-02-25 2026-02-23 S Sale
4.1
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
15,570 -2.8%
3.81
US$59,322 		15,570 -2.8% 3.81 US$59,322
2026-02-25 2026-02-23 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
10,487 -5.7%
3.81
US$39,955 		10,487 -5.7% 3.81 US$39,955
2026-02-25 2026-02-23 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,439 -4.4%
3.81
US$66,443 		17,439 -4.4% 3.81 US$66,443
2026-02-25 2026-02-23 PlS Planned sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
94,757 -5.6%
3.81
US$361,024 		94,757 -5.6% 3.81 US$361,024
2026-02-25 2026-02-23 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
10,287 -4.4%
3.81
US$39,193 		10,287 -4.4% 3.81 US$39,193
2026-02-20 2026-02-23 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
19,775
4.61
US$91,163 		19,775 4.61 US$91,163
2026-02-20 2026-02-23 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
20,163
4.61
US$92,951 		20,163 4.61 US$92,951
2026-02-20 2026-02-23 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
29,937
4.61
US$138,010 		29,937 4.61 US$138,010
2026-02-20 2026-02-23 PrS Proposed sale
4.2
John Minardo

Officer

Officer
33,528
4.61
US$154,564 		33,528 4.61 US$154,564
2026-02-20 2026-02-23 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
182,185
4.61
US$839,873 		182,185 4.61 US$839,873
2026-01-07 2026-01-05 PlS Planned sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
35,416 -11.3%
4.60
US$162,914 		35,416 -11.3% 4.60 US$162,914
2026-01-05 2026-01-05 PrS Proposed sale
4.0
RONALD SILVER

Officer

Officer
35,416
4.27
US$151,226 		35,416 4.27 US$151,226
2025-11-19 2025-11-17 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
6,016 -2.5%
3.32
US$19,973 		6,016 -2.5% 3.32 US$19,973
2025-11-14 2025-11-17 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
6,324
3.37
US$21,312 		6,324 3.37 US$21,312
2025-08-13 2025-08-11 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
1,316 -0.5%
0.84
US$1,105 		1,316 -0.5% 0.84 US$1,105
2025-08-13 2025-08-11 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
2,846 -1.0%
0.84
US$2,391 		2,846 -1.0% 0.84 US$2,391
2025-08-13 2025-08-11 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
7,754 -1.9%
0.84
US$6,513 		7,754 -1.9% 0.84 US$6,513
2025-08-13 2025-08-11 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
1,265 -0.7%
0.84
US$1,063 		1,265 -0.7% 0.84 US$1,063
2025-08-08 2025-08-11 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
1,406
0.88
US$1,237 		1,406 0.88 US$1,237
2025-08-08 2025-08-11 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
1,351
0.88
US$1,189 		1,351 0.88 US$1,189
2025-08-08 2025-08-11 PrS Proposed sale
4.2
John Minardo

Officer

Officer
8,281
0.88
US$7,287 		8,281 0.88 US$7,287
2025-05-16 2025-05-19 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
2,814
0.59
US$1,660 		2,814 0.59 US$1,660
2025-05-16 2025-05-19 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
14,661
0.59
US$8,650 		14,661 0.59 US$8,650
2025-05-20 2025-05-16 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
13,353 -1.2%
0.58
US$7,745 		13,353 -1.2% 0.58 US$7,745
2025-05-20 2025-05-16 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
2,563 -1.0%
0.58
US$1,487 		2,563 -1.0% 0.58 US$1,487
2025-02-12 2025-02-10 S Sale
4.1
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
41,269 -6.9%
1.76
US$72,633 		41,269 -6.9% 1.76 US$72,633
2025-02-12 2025-02-10 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
139,064 -10.7%
1.76
US$244,753 		139,064 -10.7% 1.76 US$244,753
2025-02-12 2025-02-10 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
38,938 -8.7%
1.76
US$68,531 		38,938 -8.7% 1.76 US$68,531
2025-02-12 2025-02-10 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
12,048 -4.1%
1.76
US$21,204 		12,048 -4.1% 1.76 US$21,204
2025-02-12 2025-02-10 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
12,052 -6.2%
1.76
US$21,212 		12,052 -6.2% 1.76 US$21,212
2025-02-07 2025-02-10 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
12,347
1.94
US$23,953 		12,347 1.94 US$23,953
2025-02-07 2025-02-10 PrS Proposed sale
4.2
John Minardo

Officer

Officer
39,889
1.94
US$77,385 		39,889 1.94 US$77,385
2025-02-07 2025-02-10 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
42,274
1.94
US$82,012 		42,274 1.94 US$82,012
2025-02-07 2025-02-10 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
142,454
1.94
US$276,361 		142,454 1.94 US$276,361
2024-12-27 2024-12-27 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
60,434
4.00
US$241,736 		60,434 4.00 US$241,736
2024-11-20 2024-11-18 S Sale
2.2
Emany Sravan Kumar

SVP, COO and CFO

Officer
11,001 -3.4%
4.08
US$44,884 		11,001 -3.4% 4.08 US$44,884
2024-11-20 2024-11-18 PlS Planned sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
5,360 -1.8%
4.08
US$21,869 		5,360 -1.8% 4.08 US$21,869
2024-11-15 2024-11-18 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
6,090
4.11
US$25,030 		6,090 4.11 US$25,030
2024-11-15 2024-11-18 PrS Proposed sale
2.2
Emany Sravan Kumar

Officer

Officer
12,500
4.11
US$51,375 		12,500 4.11 US$51,375
2024-08-14 2024-08-12 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
3,107 -1.9%
4.27
US$13,267 		3,107 -1.9% 4.27 US$13,267
2024-08-14 2024-08-12 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
9,910 -3.4%
4.27
US$42,316 		9,910 -3.4% 4.27 US$42,316
2024-08-09 2024-08-12 PrS Proposed sale
4.2
John Minardo

Officer

Officer
11,726
4.05
US$47,490 		11,726 4.05 US$47,490
2024-06-12 2024-06-10 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
22,766 -14.0%
6.29
US$143,198 		22,766 -14.0% 6.29 US$143,198
2024-06-10 2024-06-10 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
22,766
6.35
US$144,564 		22,766 6.35 US$144,564
2024-06-10 2024-06-07 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
35,574 -42.2%
6.61
US$235,144 		35,574 -42.2% 6.61 US$235,144
2024-06-07 2024-06-07 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
35,574
6.60
US$234,767 		35,574 6.60 US$234,767
2024-06-10 2024-06-06 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
44,426 -34.5%
6.36
US$282,549 		44,426 -34.5% 6.36 US$282,549
2024-06-06 2024-06-06 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
44,426
6.36
US$282,490 		44,426 6.36 US$282,490
2024-05-22 2024-05-20 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,404 -5.6%
6.45
US$112,256 		17,404 -5.6% 6.45 US$112,256
2024-05-22 2024-05-20 S Sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
22,725 -7.3%
6.45
US$146,576 		22,725 -7.3% 6.45 US$146,576
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-22 2024-05-20 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-17 2024-05-20 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
25,105
6.64
US$166,697 		25,105 6.64 US$166,697
2024-05-17 2024-05-20 PrS Proposed sale
4.2
John Minardo

Officer

Officer
19,228
6.64
US$127,674 		19,228 6.64 US$127,674
2024-05-17 2024-05-20 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
17,820
6.64
US$118,325 		17,820 6.64 US$118,325
2024-05-17 2024-05-20 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
74,705
6.64
US$496,041 		74,705 6.64 US$496,041
2024-03-08 2024-03-06 B Purchase
1.2
Duane Jon R
Non-Executive Director
6,920 +6.1%
8.70
US$60,204 		6,920 +6.1% 8.70 US$60,204
2024-03-06 2024-03-04 B Purchase
2.2
Emany Sravan Kumar

SVP, Chief Financial Officer

Officer
10,684 +3.7%
9.38
US$100,216 		10,684 +3.7% 9.38 US$100,216
2024-02-14 2024-02-12 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
38,618 -10.2%
15.24
US$588,538 		38,618 -10.2% 15.24 US$588,538
2024-02-14 2024-02-12 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
177,164 -17.5%
15.24
US$2,699,979 		177,164 -17.5% 15.24 US$2,699,979

See older Ironwood Pharmaceuticals, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Ironwood Pharmaceuticals, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Ironwood Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America